Cyprus R&D and Innovation Incentives: 120% Super-Deduction Extended to 2030
Cyprus offers a 120% R&D super-deduction on qualifying research expenditure, extended to 2030. Combined with the IP Box's ~3% effective rate on resulting IP income, Cyprus is one of Europe's most competitive jurisdictions for tech and IP-intensive businesses.
The 120% R&D Super-Deduction
Cyprus provides a 120% deduction for qualifying research and development expenditure. This means that for every €100 of eligible R&D spending, the company can deduct €120 from its taxable income — a net tax benefit equivalent to 3% of qualifying expenditure (the additional 20% deduction at the 15% CIT rate).
The super-deduction was originally introduced for a limited period and has now been extended to 31 December 2030, providing certainty for multi-year R&D projects.
Value of the Super-Deduction
On €1,000,000 of qualifying R&D spend: €1,200,000 deduction × 15% CIT = €180,000 tax saved. That's €30,000 more than a standard 100% deduction would produce.
Qualifying R&D Expenditure
Qualifying expenditure for the super-deduction includes:
- Staff costs — salaries and employer contributions for employees engaged in R&D activities
- Direct materials consumed in R&D activities
- Cost of prototypes and testing equipment (to the extent used in R&D)
- External R&D contracts with unrelated third parties (subject to limitations)
- Overhead costs directly allocated to R&D activities on a reasonable basis
Expenditure on the acquisition of IP or technology from related parties does not qualify for the super-deduction. Capital expenditure on equipment may qualify for capital allowances separately.
Combining R&D Super-Deduction with IP Box
The R&D super-deduction and the IP Box operate at different stages of the IP lifecycle and are not mutually exclusive. The strategy for a Cyprus-based IP and technology company would typically be:
- Conduct R&D in Cyprus — deduct 120% of qualifying R&D costs during the development phase
- Develop qualifying intangible assets (software, patents, trade secrets) in Cyprus
- Commercialise the IP from Cyprus — apply the IP Box 80% deduction on royalty income and other qualifying IP income
- Combined effect: reduced taxable income during development (cash-flow benefit) + ~3% effective rate on income (ongoing benefit)
Frequently Asked Questions
What is the Cyprus R&D super-deduction rate?
120% — meaning qualifying R&D expenditure is deducted at 120% of its actual cost. This generates an additional 20% deduction beyond the normal 100% expense deduction.
Until when is the Cyprus R&D super-deduction available?
The super-deduction has been extended to 31 December 2030.
Can a startup with no profits benefit from the R&D super-deduction?
Yes. The excess deduction creates or increases a trading loss, which can be carried forward indefinitely and set off against future profits. A pre-revenue R&D startup accumulates tax losses that will shelter future income.
Does the R&D super-deduction interact with the IP Box nexus fraction?
Yes — R&D expenditure incurred directly by the Cyprus company is Qualifying Expenditure (QE) in the IP Box nexus calculation. Maximising own-company R&D not only generates the 120% deduction but also increases the nexus fraction, maximising the IP Box benefit on subsequent income.
Disclaimer: This article is for informational purposes only and does not constitute legal, tax, or financial advice. Tax laws change frequently. Consult a qualified Cyprus adviser for guidance specific to your situation.
Ready to Set Up Your Cyprus Structure?
Get clear, expert guidance on incorporating, structuring, and staying compliant in Cyprus.